DSpace at RU >

Browsing by Author Vasen, H.F.

Full Text	Issue Date	Title	Author(s)
	2011	Body weight and risk of breast cancer in BRCA1/2 mutation carriers	Manders, P.; Pijpe, A.; Hooning, M.J.; Kluijt, I.; Vasen, H.F., et al
	2011	[Familial gastric cancer: diagnosis, treatment and periodic surveillance]	Kluijt, I.; Sijmons, R.H.; Hoogerbrugge, N.; Vasen, H.F.; Cats, A.
	2011	Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients	Nieuwenhuis, M.H.; Mathus-Vliegen, E.M.H.; Baeten, C.G.; Nagengast, F.M.; Bijl, J. van der, et al
	2011	High detection rate of adenomas in familial colorectal cancer	Meulen-de Jong, A.E. van der; Morreau, H.; Becx, M.C.; Crobach, L.F.; Haastert, M. van, et al
	2010	Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study.	Botma, A.; Nagengast, F.M.; Braem, M.G.; Hendriks, J.C.M.; Kleibeuker, J.H., et al
	2010	One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.	Vasen, H.F.; Abdirahman, M.; Brohet, R.; Langers, A.M.; Kleibeuker, J.H., et al
	2010	Peutz-Jeghers syndrome: a systematic review and recommendations for management.	Beggs, A.D.; Latchford, A.R.; Vasen, H.F.; Moslein, G.; Alonso, A., et al
	2010	Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.	Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S., et al
	2010	Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.	Vasen, H.F.; Moslein, G.; Alonso, A.; Aretz, S.; Bernstein, I., et al
	2010	Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.	Klift, H.M. van der; Tops, C.M.; Bik, E.C.; Boogaard, M.W.; Borgstein, A.M., et al
	2009	Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.	Wijnen, J.T.; Brohet, R.M.; Eijk, R. van; Jagmohan-Changur, S.; Middeldorp, A., et al
	2008	Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.	Nieuwenhuis, M.H.; Cappel, W De Vos Tot Nede; Botma, A.; Nagengast, F.M.; Kleibeuker, J.H., et al
	2008	Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis.	Friederich, P.; Jong, A.E. de; Mathus-Vliegen, L.M.; Dekker, E. den; Krieken, J.H.J.M. van, et al
	2008	Guidelines for the clinical management of familial adenomatous polyposis (FAP).	Vasen, H.F.; Moslein, G.; Alonso, A.; Aretz, S.; Bernstein, I., et al
	2008	Screening for prostate cancer in Dutch hereditary prostate cancer families.	Kiemeney, L.A.L.M.; Broeders, M.J.M.; Pelger, M.; Kil, P.J.M.; Schroder, F.H., et al
	2007	Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis.	Nieuwenhuis, M.H.; Mathus-Vliegen, L.M.; Slors, F.J.; Griffioen, G.; Nagengast, F.M., et al
	2007	Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).	Vasen, H.F.; Moslein, G.; Alonso, A.; Bernstein, I.; Bertario, L., et al
	2007	Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.	Nielsen, M.; Hes, F.J.; Nagengast, F.M.; Weiss, M.M.; Mathus-Vliegen, E.M.H., et al
	2007	Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.	Diergaarde, B.; Braam, H.; Vasen, H.F.; Nagengast, F.M.; Muijen, G.N.P. van, et al
	2007	Is surveillance of the small bowel indicated for Lynch syndrome families?	Kate, G.L. ten; Kleibeuker, J.H.; Nagengast, F.M.; Craanen, M.; Cats, A., et al
	2006	Decrease in mortality in Lynch syndrome families because of surveillance.	Jong, A.E. de; Hendriks, Y.M.; Kleibeuker, J.H.; Boer, S.Y. de; Cats, A., et al
	2006	Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.	Oldenburg, R.A.; Kroeze-Jansema, K.; Meijers-Heijboer, H.; Asperen, C.J. van; Hoogerbrugge-van der Linden, N., et al
	2006	What is the appropriate screening protocol in Lynch syndrome?	Jong, A.E. de; Nagengast, F.M.; Kleibeuker, J.H.; Meeberg, P.C. van de; Wijk, H.J. van, et al
	2005	Early detection of breast and ovarian cancer in families with BRCA mutations.	Vasen, H.F.; Tesfay, E.; Boonstra, H.; Mourits, M.J.E.; Rutgers, E., et al
	2005	Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP).	Nielsen, M.; Franken, P.F.; Reinards, T.H.; Weiss, M.M.; Wagner, A., et al
	2005	Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.	Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J.; Hoogerbrugge-van der Linden, N.; Verhoef, S., et al
	2005	Cost effectiveness of a new strategy to identify HNPCC patients.	Kievit, W.; Bruin, J.H.F.M. de; Adang, E.M.M.; Severens, J.L.; Kleibeuker, J.H., et al
	2005	Prevalence of adenomas among young individuals at average risk for colorectal cancer.	Jong, A.E. de; Morreau, H.; Nagengast, F.M.; Mathus-Vliegen, E.M.H.; Kleibeuker, J.H., et al
	2004	Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.	Vos tot Nederveen Cappel, W.H. de; Meulenbeld, H.J.; Kleibeuker, J.H.; Nagengast, F.M.; Menko, F.H., et al
	2004	The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.	Jong, A.E. de; Morreau, H.; Puijenbroek, M.; Eilers, P.H.; Wijnen, J.T., et al
	1997	Meat consumption and preparation, and genetic susceptibility in relation to colorectal adenomas	Voskuil, D.W.; Kampman, E.; Grubben, M.J.A.L.; Goldbohm, R.A.; Brants, H.A.M., et al
	1997	Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis	Vasen, H.F.; Bülow, S.; Myrhoj, T.; Mathus-Vliegen, L.; Griffioen, G., et al
	1996	Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis	Vasen, H.F.; Luijt, R.B. van der; Slors, J.F.M.; Buskens, E.; Ruiter, P.E. de, et al